According to a study published in Nature Reviews Immunology , people unexposed to Covid-19 may have some pre-existing immunity against the virus. However, the source and clinical relevance of the reactivity remains unknown.
The study, ‘Pre-existing immunity to SARS-CoV-2: the knowns and unknowns’, noted that people have some T-cell reactivity against SARS-CoV-2. The researchers said that it is important to define the specifics of these T-cells and assess their association with Covid-19 disease severity and vaccine responses.
According to the findings, lymphocytes, a subtype of a white blood cell in a vertebrate’s immune system, from 20-50 per cent of unexposed donors display significant reactivity to SARS-CoV-2 antigen peptide pools.
The study highlighted that pre-existing T-cell immunity to SARS-CoV-2 could be relevant because it could influence Covid-19 disease severity.
It is plausible that people with a high level of pre-existing memory CD4+ T cells that recognise SARS-CoV-2 could mount a stronger immune response upon exposure to SARS-CoV-2 and thereby limit disease severity.
The study mentioned that memory CD4+ and CD8+ T cells might also facilitate direct antiviral immunity in the lungs and nasopharynx early after exposure of the coronavirus.
Pre-existing CD4+ T-cell memory could also influence vaccination outcomes, leading to a faster or better immune response, particularly the development of neutralising antibodies, which generally depend on T-cell help.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.